feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

INVEST IN FUNDS

Lytix Biopharma: Interview with CEO Øystein Rekdal

Research Interview

2024-05-31

16:00

Redeye interviews CEO Øystein Rekdal about the Q1 2024 report.

Richard Ramanius

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.